Pro-Dex Inc (PDEX NASDAQ) stock market data APIs
$57.7233
5.15(8.9%)
as of October 30, 2026
Try our APIs with
free plan!
Pro-Dex Inc Financial Data Overview
Price chart is built with
Anychart
Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various industries; and precision machined parts and assemblies for the aerospace and defense industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Prev. Close
57.7233
Open
62.8737
High
65.6105
Low
57.5493
52 wk Range
28.81-77
Market Cap
188 M
P/E Ratio
16.022
Shares Outstanding
3 233 K
Revenue
77 548 K
EPS
0.92
Beta
0.044
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Pro-Dex Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pro-Dex Inc data using free add-ons & libraries
Get Pro-Dex Inc Fundamental Data
Pro-Dex Inc Fundamental data includes:
- Net Revenue: 77 548 K
- EBITDA: 14 385 K
- Earnings Per Share: 3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-10-29
- EPS/Forecast: 0.67
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pro-Dex Inc News
New
Align Technology (ALGN) Beats Q3 Earnings and Revenue Estimates
Align Technology (ALGN) came out with quarterly earnings of $2.8 per share, beating the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.61 per share a year ago. These figu...
ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth?
ProDex, Inc. PDEX is expected to report first-quarter fiscal 2027 results soon. The surgical-device manufacturer has entered the first quarter following robust fiscal 2026 growth, supported by higher ...
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex
For Immediate Release Chicago, IL – October 2, 2026 – Today, Zacks Equity Research discusses McKesson MCK, Cardinal Health CAH, Becton, Dickinson and Co. BDX, Merit Medical Systems MMSI and ProDe...
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
The Zacks Medical – Dental Supplies industry is benefiting from several structural healthcare shifts. Demand continues to benefit from stable healthcare utilization, continued expansion of specialty...
Get Pro-Dex Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.